Defining pre-emptive living kidney donor transplantation as a quality indicator
Wang C, Garg AX, Luo B, Kim SJ, Knoll G, Yohanna S, Treleaven D, McKenzie S, Ip J, Cooper R, Elliott L, Naylor KL. Am J Transplant. 2024; Feb 20 [Epub ahead of print].
Publications
Effect of a novel multicomponent intervention to improve patient access to kidney transplant and living kidney donation: the ENAKT LKD cluster randomized clinical trial
Garg AX, Yohanna S, Naylor KL, McKenzie SQ, Mucsi I, Dixon SN, Luo B, Sontrop JM, Beaucage M, Belenko D, Coghlan C, Cooper R, Elliott L, Getchell L, Heale E, Ki V, Nesrallah G, Patzer RE, Presseau J, Reich M, Treleaven D, Wang C, Waterman AD, Zaltzman J, Blake PG. JAMA Intern Med. 2023; Nov 3 [Epub ahead of print].
Effectiveness of a fourth COVID-19 mRNA vaccine dose against the Omicron variant in solid organ transplant recipients
Naylor KL, Knoll GA, Smith G, McArthur E, Kwong JC, Dixon SN, Treleaven D, Kim SJ. Transplantation. 2023; Aug 22 [Epub ahead of print].
Variation in kidney transplant referral across chronic kidney disease programs in Ontario, Canada
Yohanna S, Naylor KL, Luo B, Dixon SN, Bota SE, Kim SJ, Blake PG, Elliott L, Cooper R, Knoll GA, Treleaven D, Wang C, Garg AX. Can J Kidney Health Dis. 2023; 10:20543581231169608. Epub 2023 Jun 14.
Impact of study design on vaccine effectiveness estimates of 2 mRNA COVID-19 vaccine doses in patients with stage 5 chronic kidney disease
Naylor KL, McArthur E, Dixon SN, Kwong JC, Thomas D, Balamchi S, Blake PG, Garg AX, Atiqazaaman M, Hladunewich MA, Levin A, Yeung A, Oliver MJ. Kidney Int. 2023; 103(4):791-7. Epub 2023 Jan 30.
Enhance Access to Kidney Transplantation and Living Kidney Donation (EnAKT LKD): statistical analysis plan of a registry-based, cluster-randomized clinical trial
Dixon SN, Naylor KL, Yohanna S, McKenzie S, Belenko D, Blake PG, Coghlan C, Cooper R, Elliott L, Getchell L, Ki V, Mucsi I, Nesrallah G, Patzer RE, Presseau J, Reich M, Sontrop JM, Treleaven D, Waterman AD, Zaltzman J, Garg AX. Can J Kidney Health Dis. 2022; 9:20543581221131201. Epub 2022 Nov 22.
Using administrative healthcare databases to identify patients with end-stage kidney disease with no recorded contraindication to receiving a kidney transplant
Wang C, Naylor KL, Luo B, Bota SE, Dixon SN, Yohanna S, Treleaven D, Elliott L, Garg AX. Can J Kidney Health Dis. 2022; 9:1-14. Epub 2022 Jul 21.
Fracture risk of sodium-glucose cotransporter-2 inhibitors in chronic kidney disease
Cowan A, Jeyakumar N, Kang Y, Dixon SN, Garg AX, Naylor K, Weir MA, Clemens KK. Clin J Am Soc Nephrol. 2022; 17(6):835-42. Epub 2022 May 26.
Effectiveness of first, second, and third COVID-19 vaccine doses in solid organ transplant recipients: a population-based cohort study from Canada
Naylor K, Kim SJ, Smith G, McArthur E, Kwong JC, Dixon SN, Treleaven D, Knoll GA. Am J Transplant. 2022; May 16 [Epub ahead of print].
Vaccine effectiveness against SARS-CoV-2 infection and severe outcomes in the maintenance dialysis population in Ontario, Canada
Oliver MJ, Thomas D, Balamchi S, Ip J, Naylor K, Dixon SN, McArthur E, Kwong J, Perl J, Atiquzzaman M, Singer J, Yeung A, Hladunewich M, Yau K, Garg AX, Leis JA, Levin A, Krajden M, Blake PG. J Am Soc Nephrol. 2022; 33(4):839-49. Epub 2022 Mar 9.